Substrate-Controlled Divergent Reductive Cyclization of 2-Arylanilines Using CO 2 as a Switching Reagent
Organic Letters · 10.01.2025 · 27 (1) · 510-516
DOI: 10.1021/acs.orglett.4c04538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 30.12.2024. Verfasst von Qiang Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shaanxi fundamental science research project for chemistry and biology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.
- Xi'an Key Laboratory of Antiviral and Antimicrobial-Resistant Bacteria Therapeutics Research, Xi'an 710021, China.
ORCID-Profile: Jiang Nan, Chengyuan Liang
Förderung
- National Natural Science Foundation of China
- Shaanxi fundamental science research project for chemistry and biology
Zitieren
APA
Yan, Q., Nan, J., Cao, R., Zhu, L., Liu, S., Liang, C., & Zhang, C. (2025). Substrate-Controlled Divergent Reductive Cyclization of 2-Arylanilines Using CO 2 as a Switching Reagent. Organic Letters, 27(1), 510-516. https://doi.org/10.1021/acs.orglett.4c04538
Vancouver
Yan Q, Nan J, Cao R, Zhu L, Liu S, Liang C, et al. Substrate-Controlled Divergent Reductive Cyclization of 2-Arylanilines Using CO 2 as a Switching Reagent. Organic Letters. 2025;27(1):510-516. doi:10.1021/acs.orglett.4c04538
BibTeX
@article{Yan2025,
author = {Yan, Qiang and Nan, Jiang and Cao, Rui and Zhu, Lanxin and Liu, Shilei and Liang, Chengyuan and Zhang, Chen},
title = {Substrate-Controlled Divergent Reductive Cyclization of 2-Arylanilines Using CO 2 as a Switching Reagent},
journal = {Organic Letters},
year = {2025},
volume = {27},
number = {1},
pages = {510--516},
doi = {10.1021/acs.orglett.4c04538}
}
EUVIMED